Recruiting Studies
All our actively recruiting studies are listed below.
All studies have an information sheet provided. These give further information on the study and details how to express your/your child's interest in taking part.
Each study has a unique email address so please make sure that you use the correct email for the correct study. The email addresses are provided in the respective information sheets.
Avon Community-Acquired Pneumonia (AvonCAP)
Avon CAP (Community-Acquired Pneumonia) study is an observational study taking place in several hospitals in the Avon area. As part of this study, we will be recording, how many adults are admitted to hospital each year due to respiratory illness.
We want to find out more about which bacteria and viruses cause disease and whether patients with underlying medical conditions are at increased risk of certain infections.
The study is coordinated by the Bristol Vaccine Centre (University of Bristol) and is funded by Pfizer. It has been approved by the Health Research Authority and East of England - Essex Research Ethics Committee.
For further information on this study, please visit AvonCAP's further study details pages.
AvonCAP GP2
Title: General practice study about chest infections
AvonCAP GP2 looks into chest infections and worsening asthma, COPD and heart failure. Our aim is to record every adult case with this diagnosis in the GP surgeries taking part in the AvonCAP Study.
To find out more, please click here.
6-in-1 (Part 2) - Vaccine paediatric study
Title: Heterologous Boosting for Hexavalent Paediatric Vaccines in the UK Schedule
The purpose of the study is to evaluate proposed changes to the UK childhood vaccination schedule.
One of the vaccines currently given to 12-month-old children in the UK routine immunisation programme, Menitorix, will no longer be available after 2025. Menitorix protects against two bacterial infections, Haemophilus influenzae type b (Hib) and group C meningococcus (MenC). Both infections can cause serious illnesses in children. The immunisation programme will therefore need to be modified. The Joint Committee on Vaccination and Immunisation (JCVI), the independent expert group which advises on vaccination policy in the UK, has considered various possible options for adapting the current schedule. This study is to evaluate the proposed schedule which is most likely to be adopted.
Children taking part in our study will be offered one or two doses of a vaccine which helps protect against chickenpox.
If you have a query about the study, please refer to the study information booklet before contacting the study team:
Or visit our website, where you can find the screening questionnaire:
https://trials.ovg.ox.ac.uk/trials/6-1-part-2-vaccine-study-bristol-royal-hospital-children